BNB Soars to New All-Time High Amid Windtree Therapeutics' Nasdaq Delisting

BNB has reached a new all-time high, surpassing the $880 mark, even as Windtree Therapeutics (WINT) faces delisting from the Nasdaq. The biotech firm's stock plunged 76% after Nasdaq announced the suspension of trading due to noncompliance with listing rules, specifically failing to maintain a minimum bid price of $1 for 30 consecutive business days.